4//SEC Filing
HAUMANN BRETT K 4
Accession 0001179110-20-011367
CIK 0001583107other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:16 PM ET
Size
4.4 KB
Accession
0001179110-20-011367
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2020-11-20$17.21/sh−4,639$79,837→ 278,171 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 6:16 PM ET
- Size
- 4.4 KB